|
Form Serial Number: |
DA20240619E00389
|
1.
Date of relevant event: |
14/06/2024 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
00241 |
4.
Name of listed corporation: |
Alibaba Health Information Technology Ltd. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
16,091,736,264 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
TU |
(Other names) |
YANWU |
|
|
|
10.
Name of director (Chinese): |
屠燕武 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
11031 | The number of shares in which you are interested has increased because: you became the holder of, wrote or issued equity derivatives under which (choose one): you have a right to take the underlying shares | |
|
2501 | Other (you must describe the capacity in the Supplementary Information box) | |
696,600 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 1,701,678 | 0.01 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 2,398,278 | 0.01 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4106 | Unlisted derivatives - Cash settled |
| 15/06/2021 | 14/06/2030 | HKD | 0 | HKD | 19.940 | HKD | 0.000 | 145,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/06/2024 | | HKD | 0 | HKD | 0.000 | HKD | 0.000 | 14,500 |
Long position | 4106 | Unlisted derivatives - Cash settled |
| 15/06/2022 | 14/06/2031 | HKD | 0 | HKD | 18.212 | HKD | 0.000 | 67,250 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/06/2024 | 15/06/2025 | HKD | 0 | HKD | 0.000 | HKD | 0.000 | 13,450 |
Long position | 4106 | Unlisted derivatives - Cash settled |
| 15/06/2023 | 14/06/2032 | HKD | 0 | HKD | 4.920 | HKD | 0.000 | 283,250 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/06/2024 | 15/06/2026 | HKD | 0 | HKD | 0.000 | HKD | 0.000 | 84,975 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/06/2024 | 15/06/2027 | HKD | 0 | HKD | 0.000 | HKD | 0.000 | 102,300 |
Long position | 4106 | Unlisted derivatives - Cash settled |
| 15/06/2024 | 14/06/2033 | HKD | 0 | HKD | 5.160 | HKD | 0.000 | 255,750 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/06/2025 | 15/06/2028 | HKD | 0 | HKD | 0.000 | HKD | 0.000 | 696,600 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Box 24: Restricted share units granted by Alibaba Health Information Technology Limited. Box 27: Restricted share units and share options granted by Alibaba Health Information Technology Limited. Box 28: The exercise period in respect of 14,500 shares has already ended on 15 June 2024.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
19/06/2024 (dd/mm/yyyy)
|
|